Aberrant and ectopic cell populations in restrictive allograft syndrome after lung transplantation
European Respiratory Journal · 2026
DOI: 10.1183/13993003.00537-2025 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Respiratory Journal, 2026. Verfasst von Lena M Leiber und 30 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine and Infectious Diseases, Hannover Medical School, Hannover, Germany. Hauptthemen laut MEDLINE: Lung Transplantation, Lung, Pulmonary Fibrosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NHLBI NIH HHS, Three Lakes Foundation, National Heart, Lung, and Blood Institute.
Abstract (Originalsprache)
Rationale
Restrictive allograft syndrome (RAS) is a major cause of mortality following lung transplantation due to progressive fibrosis of the lung allograft, with no therapeutic options. Knowledge of the cellular and molecular mechanisms driving fibrosis in RAS remains limited.
Objective
To characterise the cellular and molecular changes in human RAS lungs through single-nucleus transcriptomic profiling.
Methods
Single-nucleus RNA-sequencing (snRNA-seq) was performed in peripheral lung tissues from 15 RAS patients undergoing lung re-transplantation, and from nine healthy control lungs. Findings were validated and extended using histological techniques including immunofluorescence, RNA in situ hybridisation, Elastica van Gieson immunohistochemistry, quantitative histological analyses, and micro-computed tomography (CT) scans. Measurements and main results snRNA-seq analysis of RAS lungs revealed previously undescribed aberrant basaloid cells, ectopic COL15A1 + peribronchial vascular endothelial cells (pVECs), and CTHRC1 + fibrotic fibroblasts. Histological stains disclosed distinctive distribution patterns: aberrant basaloid cells, primarily localised at the fibrotic edge, together with juxtaposed CTHRC1 + fibrotic fibroblasts and ectopic COL15A1 + pVECs form the fibrotic niche of alveolar fibroelastosis (AFE). PRX + alveolar microvasculature is partially lost in AFE areas. Micro-CT scans revealed changes from pulmonary to systemic perfusion, facilitated by COL15A1 + pVECs. Lastly, our data reveal potential therapeutic targets in RAS, including integrin αvβ6, activator of transforming growth factor-β.
Conclusion
Considering the multifaceted differences of RAS and idiopathic pulmonary fibrosis, we revealed a surprising general principle of an entity-spanning composition of the fibrotic niche by aberrant basaloid cells localised at the fibrotic edge, ectopic COL15A1 + pVECs and CTHRC1 + fibrotic fibroblasts. This suggests a flexible, but cellular pathogenesis-guided, transferability of potential therapeutic approaches between progressive fibrotic lung diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Respiratory Medicine and Infectious Diseases, Hannover Medical School, Hannover, Germany.
- Biomedical Research in Endstage and Obstructive Lung Disease Hannover, German Center for Lung Research, Hannover, Germany.
- Institute of Pathology, Hannover Medical School, Hannover, Germany.
- Institute of Human Genetics, Hannover Medical School, Hannover, Germany.
- Institute of Pathology, RWTH Aachen, Aachen, Germany.
- Service de Pneumologie, CHU de Caen, Centre de compétence des maladies pulmonaires rares, ISTCT, UMR6030-CNRS-CEA-Université de Caen, Caen, France.
ORCID-Profile: Lena M Leiber, Jannik Ruwisch, Edith K J Schwarz, Jan C Kamp, Mark Greer, Mark Kühnel, Christopher Werlein, Aurelien Justet, Anke K Bergmann, Hanne Beeckmans, Matthias Ballmaier, Robin Vos, Lars Knudsen, Ulrich Martin, Bart M Vanaudenaerde, Ali Önder Yildirim, Jens M Hohlfeld, Fabio Ius, Florian Laenger, Tobias Welte, Christine Falk, Naftali Kaminski, Danny D Jonigk, Jens Gottlieb, Jonas C Schupp
Förderung
- NHLBI NIH HHS
- Three Lakes Foundation
- National Heart, Lung, and Blood Institute
- Deutsches Zentrum für Lungenforschung
- Else Kröner-Fresenius-Stiftung
Zitieren
APA
Leiber, L. M., Christian, L., Neubert, L., Ruwisch, J., Yilmaz, H., Schwarz, E. K. J., Langer, L. T., Kamp, J. C., Greer, M., Haermeyer, B., Kühnel, M., Werlein, C., Justet, A., Bergmann, A. K., Beeckmans, H., Ballmaier, M., Salman, J., Vos, R., Knudsen, L., …, & Schupp, J. C. (2026). Aberrant and ectopic cell populations in restrictive allograft syndrome after lung transplantation. European Respiratory Journal. https://doi.org/10.1183/13993003.00537-2025
Vancouver
Leiber LM, Christian L, Neubert L, Ruwisch J, Yilmaz H, Schwarz EKJ, et al. Aberrant and ectopic cell populations in restrictive allograft syndrome after lung transplantation. European Respiratory Journal. 2026. doi:10.1183/13993003.00537-2025
BibTeX
@article{Leiber2026,
author = {Leiber, Lena M and Christian, Leonard and Neubert, Lavinia and Ruwisch, Jannik and Yilmaz, Hande and Schwarz, Edith K J and Langer, Linus T and Kamp, Jan C and Greer, Mark and Haermeyer, Bernd and Kühnel, Mark and Werlein, Christopher and Justet, Aurelien and Bergmann, Anke K and Beeckmans, Hanne and Ballmaier, Matthias and Salman, Jawad and Vos, Robin and Knudsen, Lars and Martin, Ulrich and Vanaudenaerde, Bart M and Yildirim, Ali Önder and Hohlfeld, Jens M and Ius, Fabio and Laenger, Florian and Welte, Tobias and Falk, Christine and Kaminski, Naftali and Jonigk, Danny D and Gottlieb, Jens and Schupp, Jonas C},
title = {Aberrant and ectopic cell populations in restrictive allograft syndrome after lung transplantation},
journal = {European Respiratory Journal},
year = {2026},
doi = {10.1183/13993003.00537-2025}
}
EUVIMED